Analytical Study on Relationship between Cell-Free Plasma DNA Concentration and Clinicopathological Features in Breast Cancer

Article Information

Song-Hak Kim1, Un-Rim Sim1*, Chong-Won Ri2, Hui-Myong Pak2, Chol-Ho Ri3Yong-Suk Kim1, Myong-Nam Kim1

1Department of Molecular Biology, Pyongyang Medical College, KIM IL SUNG University, Pyongyang, Democratic People’s Republic of Korea

2Breast Oncology institute, Pyongyang Maternity Hospital, Pyongyang, Democratic People’s Republic of Korea

3Oncology institute, Academy of Medical Science, Pyongyang, Democratic People’s Republic of Korea

*Corresponding author: Un-Rim Sim, Department of Molecular Biology, Pyongyang Medical College, KIM IL SUNG University, Pyongyang, Democratic People’s Republic of Korea

Received: 26 December 2019; Accepted: 06 January 2020; Published: 15 January 2020

Citation:

Song-Hak Kim, Un-Rim Sim, Chong-Won Ri , Hui-Myong Pak, Chol-Ho Ri, Yong-Suk Kim, Myong-Nam Kim. Analytical Study on Relationship between Cell-Free Plasma DNA Concentration and Clinicopathological Features in Breast Cancer. Archives of Internal Medicine Research 3 (2020): 026-031.

View / Download Pdf Share at Facebook

Abstract

Background: Breast cancer is the most fatal form of cancer for female population and non-invasive method for early detection of human cancers is a promising way to provide more quality health service to the population.

Objectives: In this study, we made basic data that can evaluate the progression of breast cancer by explaining the relationship between cell-free plasma DNA concentration and clinicopathological features in breast cancer.

Methods: Cell free DNA levels were measured in plasma of breast cancer, breast benign disease and healthy people.

Results: Cell-free plasma DNA concentration in breast cancer was significantly higher than in healthy individuals and breast benign disease. (p<0.001, p<0.001, p=0.002) Plasma free DNA concentration was significantly higher as the size of tumor was getting bigger, as tumor differentiation was getting lower, and as pTNM stage was getting higher. And also it was higher in a lymph node positive than negative (p<0.001). Postsurgical plasma free DNA concentration was significantly lower than presurgical concentration. (p<0.001) So we could estimate lymph node metastasis and effect of operation as well as development and progression in breast cancer.

Conclusion: Plasma free DNA concentration is related to progression and metastasis and it can be used as a remarkable biomarker to assess progression of breast cancer, lymph node metastasis and effect of the operation.

Keywords

Breast Cancer, Cell-Free DNA, Plasma Free DNA, Clinicopathological Features

Breast Cancer articles Breast Cancer Research articles Breast Cancer review articles Breast Cancer PubMed articles Breast Cancer PubMed Central articles Breast Cancer 2023 articles Breast Cancer 2024 articles Breast Cancer Scopus articles Breast Cancer impact factor journals Breast Cancer Scopus journals Breast Cancer PubMed journals Breast Cancer medical journals Breast Cancer free journals Breast Cancer best journals Breast Cancer top journals Breast Cancer free medical journals Breast Cancer famous journals Breast Cancer Google Scholar indexed journals Cell-Free DNA articles Cell-Free DNA Research articles Cell-Free DNA review articles Cell-Free DNA PubMed articles Cell-Free DNA PubMed Central articles Cell-Free DNA 2023 articles Cell-Free DNA 2024 articles Cell-Free DNA Scopus articles Cell-Free DNA impact factor journals Cell-Free DNA Scopus journals Cell-Free DNA PubMed journals Cell-Free DNA medical journals Cell-Free DNA free journals Cell-Free DNA best journals Cell-Free DNA top journals Cell-Free DNA free medical journals Cell-Free DNA famous journals Cell-Free DNA Google Scholar indexed journals Plasma Free DNA articles Plasma Free DNA Research articles Plasma Free DNA review articles Plasma Free DNA PubMed articles Plasma Free DNA PubMed Central articles Plasma Free DNA 2023 articles Plasma Free DNA 2024 articles Plasma Free DNA Scopus articles Plasma Free DNA impact factor journals Plasma Free DNA Scopus journals Plasma Free DNA PubMed journals Plasma Free DNA medical journals Plasma Free DNA free journals Plasma Free DNA best journals Plasma Free DNA top journals Plasma Free DNA free medical journals Plasma Free DNA famous journals Plasma Free DNA Google Scholar indexed journals Clinicopathological Features articles Clinicopathological Features Research articles Clinicopathological Features review articles Clinicopathological Features PubMed articles Clinicopathological Features PubMed Central articles Clinicopathological Features 2023 articles Clinicopathological Features 2024 articles Clinicopathological Features Scopus articles Clinicopathological Features impact factor journals Clinicopathological Features Scopus journals Clinicopathological Features PubMed journals Clinicopathological Features medical journals Clinicopathological Features free journals Clinicopathological Features best journals Clinicopathological Features top journals Clinicopathological Features free medical journals Clinicopathological Features famous journals Clinicopathological Features Google Scholar indexed journals cancer articles cancer Research articles cancer review articles cancer PubMed articles cancer PubMed Central articles cancer 2023 articles cancer 2024 articles cancer Scopus articles cancer impact factor journals cancer Scopus journals cancer PubMed journals cancer medical journals cancer free journals cancer best journals cancer top journals cancer free medical journals cancer famous journals cancer Google Scholar indexed journals residual disease articles residual disease Research articles residual disease review articles residual disease PubMed articles residual disease PubMed Central articles residual disease 2023 articles residual disease 2024 articles residual disease Scopus articles residual disease impact factor journals residual disease Scopus journals residual disease PubMed journals residual disease medical journals residual disease free journals residual disease best journals residual disease top journals residual disease free medical journals residual disease famous journals residual disease Google Scholar indexed journals fibroadenosis articles fibroadenosis Research articles fibroadenosis review articles fibroadenosis PubMed articles fibroadenosis PubMed Central articles fibroadenosis 2023 articles fibroadenosis 2024 articles fibroadenosis Scopus articles fibroadenosis impact factor journals fibroadenosis Scopus journals fibroadenosis PubMed journals fibroadenosis medical journals fibroadenosis free journals fibroadenosis best journals fibroadenosis top journals fibroadenosis free medical journals fibroadenosis famous journals fibroadenosis Google Scholar indexed journals DNA concentration articles DNA concentration Research articles DNA concentration review articles DNA concentration PubMed articles DNA concentration PubMed Central articles DNA concentration 2023 articles DNA concentration 2024 articles DNA concentration Scopus articles DNA concentration impact factor journals DNA concentration Scopus journals DNA concentration PubMed journals DNA concentration medical journals DNA concentration free journals DNA concentration best journals DNA concentration top journals DNA concentration free medical journals DNA concentration famous journals DNA concentration Google Scholar indexed journals menstruation articles menstruation Research articles menstruation review articles menstruation PubMed articles menstruation PubMed Central articles menstruation 2023 articles menstruation 2024 articles menstruation Scopus articles menstruation impact factor journals menstruation Scopus journals menstruation PubMed journals menstruation medical journals menstruation free journals menstruation best journals menstruation top journals menstruation free medical journals menstruation famous journals menstruation Google Scholar indexed journals Body Mass Index (BMI) articles Body Mass Index (BMI) Research articles Body Mass Index (BMI) review articles Body Mass Index (BMI) PubMed articles Body Mass Index (BMI) PubMed Central articles Body Mass Index (BMI) 2023 articles Body Mass Index (BMI) 2024 articles Body Mass Index (BMI) Scopus articles Body Mass Index (BMI) impact factor journals Body Mass Index (BMI) Scopus journals Body Mass Index (BMI) PubMed journals Body Mass Index (BMI) medical journals Body Mass Index (BMI) free journals Body Mass Index (BMI) best journals Body Mass Index (BMI) top journals Body Mass Index (BMI) free medical journals Body Mass Index (BMI) famous journals Body Mass Index (BMI) Google Scholar indexed journals

Article Details

1. Introduction

Many studies have reported that the cell-free DNA level was low in the serum or plasma of healthy people, but it was high in patients with cancer or apparent diseases [1]. Cell-free DNA is released from tumor and normal cells by different mechanisms, including necrosis and apoptosis making it a challenging analyte owing to its high degree of fragmentation [2 ,3 ,4]. Cell-free DNA in cancer patients may be either tumor derived or released from injured host blood or vascular tissues by both apoptotic and necrotic cell death [5, 6]. So circulating cell-free DNA is a important biomarker for early detection of cancer, residual disease, monitoring chemotherapy and other aspects of cancer management [7].  As a result of this, by explaining the relationship between plasma free DNA concentration and clinicopathological features, we attached importance to making basis by which can assess progression of breast cancer.

1.1 Subjects

From September, 2016 to August, 2017, the subjects used in this study were 108 patients with breast cancer who were diagnosed primary breast cancer and received breast cancer surgery at the oncology institution. And there were 36 patients with fibroadenosis, 12 patients of phyllodes tumor and 39 relative healthy volunteers.

2. Methods

We set the clinicopathological features and collected data in accordance with document and consultation, clinicopatholography. Plasma free DNA was separated using   AxyPrepTM Multi source Genomic DNA Miniprep Kit. Plasma free DNA concentration was measured using Nano-drop for nucleic concentration measurement.

3. Results and Discussion

On the basis of that Plasma free DNA concentration is related to progression and metastasis and it can be used as a remarkable biomarker for treatment effect and prognosis assessment [7, 8, 9, 10, 11, 12] we attached importance to making basis by which can assess progression of breast cancer, lymph node metastasis and effect of operation by explaining the relationship between plasma free DNA concentration and clinicopathological features.

3.1 Plasma free DNA concentration in relative healthy people and patients with breast benign disease and breast cancer

Plasma free DNA concentration was significantly higher in patients with fibroadenosis(117.3 ± 8.5ng•mL-1), phyllodes tumor (224.0 ± 81.4 ng•mL-1), breast cancer (636.9 ± 33.7ng•mL-1) than in realative healthy individuals (53.6 ± 3.9ng•mL-1) (p<0.001). It was significantly higher in phyllodes tumor and breast cancer than in fibroadenosis (p=0.028, p<0.001) and significantly higher in breast cancer than in phyllodes tumor. (p=0.002) (Table 1). So measurement of plasma free DNA concentration can help us differentiate breast benign disease and breast cancer.

3.2 Relationship between cell-free plasma DNA  concentration and clinical features in breast cancer

Table 2 and 3 shows the concentration of plasma free DNA with age, family history of cancer, menstruation related indices, Body Mass Index (BMI) as an obesity index in breast cancer. Correlation coefficient with age was -0.171, so there was somewhat reversed correlation.  And the Plasma free DNA concentration was significantly higher in patients aged under 40 (734.5 ± 92.4 ng•mL-1) than aged after 50 (556.1 ± 36.1 ng•mL-1)( p<0.039) (Table 2). There was no significant difference between presence and absence of cancer family history (Table 2). There was no significant difference between presence and absence of menopause, but there was a falling tendency in patients with menopause (Table 2). And then there was no relationship between plasma free DNA concentration and menopausal age (r=-0.038) (Table 3). There was no correlation between plasma free DNA concentration and BMI, the menarche, age in patients with breast cancer. (r=0.036, 0.051) (Table 3) And we examined the relationship between plasma free DNA concentration and related pregnancy, delivery, abortion indices. There was no correlation between plasma free DNA concentration and the numbers of pregnancy, delivery and abortion (r=-0.05, 0.07, 0.062).

3.3 Relationship between cell-free plasma DNA concentration and pathological features in breast cancer

Table 4 shows the concentration of plasma free DNA as tumor size, lymph node metastasis, tumor differentiation, pTNM stage in breast cancer. As shown in table 4, plasma free DNA concentration was significantly higher in more than 2cm tumor (538.3 ± 30.3ng•mL-1), compared to less than 2cm tumor (431.1 ± 34.1ng•mL-1) (p=0.024).  So we could determine that the size of tumor affects the concentration of plasma free DNA. And we think that the larger the size of tumor is, the more the proliferative and necrotizing tumor cells are. As shown in table 4, plasma free DNA concentration was significantly higher in group with lymph node positive (629.0 ± 45.3ng•mL-1) than in group with lymph node negative (434.6 ± 22.7ng•mL-1) (p<0.001). So we could determine that these features could be used in explaining the presence of lymph node. And we think the tumor related free DNA is released in metastasized lymph node as well as local tumor and it affects the whole plasma free DNA concentration.  As shown in table 4, plasma free DNA concentration was significantly higher in low and undifferentiation (533.9 ± 27.4ng•mL-1) than in high and middle differentiation (435.6 ± 23.9ng•mL-1) (p<0.001). As shown in table 4, plasma free DNA concentration was significantly lower in II and I (494.9 ± 29.2 ng•mL-1, 408.8 ± 34.1ng•mL-1)    than in III stage (785.0 ± 25.5ng•mL-1) (p<0.001). Our study suggests that the measurement of plasma free DNA may be used for the assessment of breast cancer development and distant metastasis and so on.

3.4 Presurgical and postsurgical cell-free plasma DNA concentration in breast cancer

As shown in Table 5, postsurgical plasma free DNA concentration(162.7 ± 11.4ng•mL-1)  was significantly lower than the presurgical concentration (496.0 ± 23.4ng•mL-1) (p<0.001). So we could decide the effect of operation through the measurement of plasma free DNA concentration.  We could conclude that Plasma free DNA concentration may be used for assessment of breast cancer development, progression, distant metastasis as well as the effect of the operation and prognosis and it can be used as a remarkable biomarker in clinical practice.

Division

No.

Plasma free DNA concentration (ng/ml blood)

P1

P2

P3

 

95% CI

Realative Healthy People

39

53.6 ± 3.9

45.7~71.6

-

   

Fibroadenosis

36

117.3 ± 8.5

99.6~134.9

<0.001

-

 

Phyllodes

12

224.0 ± 81.4

114.8~383.2

<0.001

0.028

-

Breast Cancer

108

636.9 ± 33.7

570.1~703.7

<0.001

<0.001

0.002

Table 1: Cell-free plasma DNA concentration in relatively healthy people and breast benign disease and breast cancer.

Features

No.

Plasma free DNA concentration (ng/ml)

P1

P2

 

95% CI

Age

?39

12

734.5 ± 92.4

531.0~937.9

-

 

40~49

50

627.1 ± 36.5

553.7~700.4

0.226

-

50>

46

556.1 ± 36.1

483.3~628.7

0.039

0.172

P1; vs patients under 39, P2; vs patients aged from 40 to 49

Family history of cancer

+

18

561.9 ± 52.3

451.6~672.2

0.409

 

-

90

618.9 ± 28.6

562.1~675.8

 

P; vs presence of family history

Presence of menopause

+

48

554.8 ± 35.4

483.5~626.1

0.058

 

-

60

652.0 ± 35.1

581.8~722.1

 

P; vs presence

Table 2: Relationship between cell-free plasma DNA concentration and clinical features (1).

Division

(ng/ml)

95% CI

Correlation coefficient

BMI (kg/m2) (n=108)

21.9 ± 0.1

21.6~22.2

0.036

Plasma free DNA concentration

636.9 ± 33.7

570.0~703.7

menarche age (n=108)

15.4 ± 0.2

14.9~15.9

0.051

Plasma free DNA concentration

636.9 ± 33.7

570.0~703.7

menopausal age (n=48)

48.6 ± 0.5

47.7~49.5

-0.038

Plasma free DNA concentration

554.8 ± 35.4

483.5~626.1

Table 3: Relationship between cell-free plasma DNA concentration and clinical features(2).

Variable

No.

Plasma free DNAconcentration (ng/ml)

P1

P2

 

95% CI

size

<2.0

30

431.1 ± 34.1

361.4~500.7

-

0.024

 

≥2.0

46

538.3 ± 30.3

477.1~599.5

Lymph node metastasis

         

negative

52

434.6 ± 22.7

388.9~480.2

-

 

positive

24

629.0 ± 45.3

535.2~722.8

<0.001

 

Differentiation

         

High, middle differntiation

22

435.6 ± 23.9

385.9~485.2

-

 

Low, undifferntiation

54

533.9 ± 27.4

478.9~588.8

<0.001

 

pTNM staging

         

I

26

408.8 ± 34.1

338.6~478.9

-

 

II

42

494.9 ± 29.2

435.9~553.8

0.065

-

III

8

785.0 ± 25.5

724.7~845.3

<0.001

<0.001

P1;vs I stage, P2;vs II stage

Table 4: Relationship between cell-free plasma DNA concentration and pathological features.

Division

Plasma free DNA concentration (ng/ml)

P

 

95% CI

Presurgical

496.0 ± 23.4

449.3~542.6

-

postsurgical

162.7 ± 11.4

139.9~185.4

<0.001

Table 5: Presurgical and postsurgical cell-free plasma DNA concentration (n=76).

4. Conclusion

In summary, we analyzed cell-free plasma DNA concentration and examined the relationship between plasma free DNA concentration and clinicopathological features in breast cancer First, Cell-free plasma DNA concentration in breast cancer was respectively higher by 1188%, 543%, 284% than in healthy individuals, Fibroadenosis and Phyllodes tumor. (p<0.001, p<0.001, p=0.002) Second, Plasma free DNA concentration was respectively 24%, 23%, 59% higher as the size of the tumor was getting bigger, as tumor differentiation was getting lower, and as pTNM stage was getting higher. And also it was 45% higher, in lymph node positive than negative. (p<0.001) Third, Postsurgical plasma free DNA concentration was significantly lower by 33% than presurgical concentration. (p<0.001) These findings suggest that plasma free DNA concentration may be a useful factor in determining progression of breast cancer, lymph node metastasis and effect of operation. Furthermore, it may be used in devising strategy of breast cancer treatment in the future.

Funding

None

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. Wu TL, Zhang D, Chia JH, et al. Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin Chim Acta 321 (2002): 77-87.
  2. Jiang N, Pisetsky DS. The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum. J Leukoc Biol 77 (2005): 296-302.
  3. Zanetti-Dallenbach RA, Schmid S, Wight E, et al. Levels of circulating cell-free serum DNA in benign and malignant breast lesions. Int J Biol Markers 22 (2007): 95-99.
  4. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer–a survey. Biochim Biophys Acta 1775 (2007): 181-232.
  5. Stroun M, Lyautey J, Lederrey C, et al. About the possible origin, and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 313 (2001): 139-142.
  6. Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients:quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61 (2001): 1659-1665.
  7. Pantel K. Circulating tumor cells in cancer patients: Challenges and perspectives. Trends Mol. Med 16 (2010): 398-406.
  8. Green ED, Rubin EM, Olson MV. The future of DNA sequencing. Nature 550 (2017): 179-181.
  9. Anja van de Stolpe, Jaap M J den Toonder. Circulating Tumor Cells: What Is in It for the Patient? A Vision towards the Future. Cancers 6 (2014): 1195-1207
  10. Yu-Kwan Tsong, Dennis Lo YM. Diagnostic developments involving cell-free (circulating) nucleic acids. Clinica Chimica Acta 2006; 363: 187- 196
  11. Schwarzenbach H, Alix-Panabieres C, Muller I, et al. Cell-free Tumor DNA in Blood Plasma as a Marker for Circulating Tumor Cells in Prostate Cancer. Clin Cancer Res15 (2009): 1032-1038.
  12. Carmela Nicolini, Cíntia Ens, Talita Cerutti, et al. Elevated Level of Cell-free Plasma DNA is Associated with Advanced-Stage Breast Cancer and Metastasis. Clin Chem Lab Med 51 (2013):  277-278.

© 2016-2024, Copyrights Fortune Journals. All Rights Reserved